Pradaxa Side Effects

Causing Internal Bleeding, Cerebral Hemorrhage / Death

Recent reports have linked Pradaxa, a blood thinner used for atrial fibrillation, with serious side effects including:

• Internal bleeding (Gastrointestinal bleeding - GI Bleed)
• Cerebral hemorrhage
• Brain hemorhage
• Ulcers
• Kidney Bleeding
• Death

We are investigating Pradaxa side effect cases in all 50 states.

If you or a loved one suffered from any of the above side effects including internal bleeding, cerebral and/or brain hemorrhage, ulcers or even death after taking Pradaxa please contact Nadrich & Cohen. Inquiries are strictly confidential. Your email will not be used for any other purpose or sold to any third party.

Remember, Pradaxa is a blood thinner which has sadly been connected with internal bleeding and internal hemorrhaging. The actual condition is called padigatran etexilate. Pradaxa is used to help reduce the risk of stroke due to atrial fibrillation. The first connection between Pradaxa and uncontrolled bleeding occurred after studies were done on elderly patients in New Zealand. It was found that the internal bleeding was uncontrollable. This, of course, leads to catastrophic consequences.

We are investigating Pradaxa cases throughout the country. If you or your loved one suffered from side effects including internal bleeding from Pradaxa, please contact us immediately. Please call us at 1-800-718-4658.

Pradaxa (dabigatran) was brought to market in October 2010 as a blood thinner for patients diagnosed with atrial fibrillation. It is in the class of anticoagulant (anti-clotting) blood thinners knows as direct thrombin inhibitors. It is a single fixed dose treatment. Pradaxa was additionally used off label for other purposes.

Pradaxa carries a greater risk for side effects than its label describes. By January 1, 2012 the FDA had compiled over 300 reports of Pradaxa side effects. As of October 31, 2011 numerous deaths due to internal bleeding problems worldwide were reported by the manufacturer.

Our law firm is investigating internal bleeding Pradaxa side effect claims in all 50 states. We are investigating the manufacturer, Boehringer Ingelheim’s not adequately researching the side effects of the drug before Pradaxa came to market or correctly warning of its serious side effects on the drugs label.

If we pursue a Pradaxa claim on behalf of you or a loved one we will do so on a contingency fee basis which means there are never any fees or out of pocket expenses from you until a recovery is obtained.

Remember, Nadrich & Cohen does not recommend anyone taking or not taking medication without their doctor’s approval. Please consult your doctor and not any lawyer on any matters related to your health. By all means, all patients should talk to their physicians to decide the benefits and risks of Pradaxa or any other medication in order to make a correct choice for them.

Contact us today.

Latest News

April, 2012
The first Pradaxa lawsuits have been filed in March 2012 in Kentucky, Louisiana, and Tennessee.

Pradaxa causes an increased risk for developing bleeding or hemorrhaging which cannot stop. This is due to the incorrect chemical compounds of Pradaxa. Unfortunately (sadly) these bleeds cannot be stopped because there is no reversal antidote known.

In December 2011 the FDA released a report stating that they were investigating serious bleeding events in Pradaxa patients. The manufacturer has reported that there have been at least 250 fatal bleeding events worldwide due to Pradaxa between March 2008 and October 2011.

Most of the lawsuits concern uncontrolled gastrointestinal bleeding.

Our lawsuits, which we plan on filing on behalf of our Pradaxa victims, will include complaints for failure to warn, negligence, breach of warranty, design defect and fraud.

If you or a loved one suffered non-controllable leading to hospitalization, stroke or death or other significant injuries please contact a Pradaxa intake specialist at Nadrich & Cohen. We have an intake specialist available for you at 1-800-718-4658.

If you would like to fill out a free case review please do so on the right.

January 12th, 2012
The Journal of Neurosurgery reported that Pradaxa bleeding is so serious that it can lead to death. Reuters News has quoted this neurosurgery article by printing the story of an 83 year old man who had used Pradaxa for approximately four weeks and then fell in his home. Soon after admission to the hospital he suffered a brain hemorrhage, fell into a coma and died. The report stated in the neurosurgery article that. "Use of this drug (Pradaxa) becomes more widespread, more intracranial hemorrhage resulting from even minor trauma may occur with increased frequency."

Pradaxa was approved in October 2010 to prevent strokes with those who had atrial fibrillation - a diagnosis mostly seen in the over 65 population.

The January 12th, 2012 report in the Institute for Safe Medication Practices concluded that Pradaxa has caused hundreds of adverse event reports filed with the Federal Drug Administration (FDA) in just the first quarter of 2011. Amongst these adverse event reports included 120 deaths, 25 cases of permanent disability and over 500 cases of hospitalization. Of the over 900 cases reported over 500 cases involved hemorrhage.

We are currently investigating Pradaxa hemorrhage cases in all 50 states. We believe that the manufacturer of Pradaxa, Boehringer Ingelheim, failed to adequately warn Pradaxa users about the risks connected to Pradaxa, mainly fatal bleeding and / or hemorrhaging.